Skip to content

Released Nov 7, 2016, after the close

10-Q filed Nov 7, 2016, 38 days after period end · 0001558370-16-009519

Q3 2016 · 10-Q
Revenue$66.11M+67.1% vs Q3 2015+21.6% vs Q2 2016
Net Income-$33.20Mno prior Q3 2015 on fileN/M vs Q2 2016
EPS Diluted-$0.23N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$28,287,000N/M
Operating Cash Flowderived-$645,000N/M
Free Cash Flowderived-$2,030,000N/M
Margins · derived
Operating margin-42.8%+23.4 pt vs Q3 2015
Net margin-50.2%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2016Q3 2015Q3 2014Q3 2013
Revenue$66.11M$39.57M$16.92M$4.93M
Net Income-$33.20M——-$61.78M
EPS Diluted-$0.23-$0.33-$0.30-$0.51

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR